HB 5458 creates a new Genetic Counselors Practice Act under West Virginia law, directly affecting individuals seeking to practice genetic counseling in the state. The bill requires criminal background checks for all new genetic counseling license applicants, mandates that practitioners hold a valid license before providing services, and defines the scope of genetic counseling practice. It prohibits genetic counselors from representing themselves as licensed physicians and establishes penalties including up to two years in prison or a $2,000 fine for violations. The bill also sets continuing education requirements, licensure renewal processes, and disciplinary procedures specific to genetic counselors.
HB 4474 extends the expiration date of West Virginia's Alzheimer's Disease and Other Dementia Advisory Council, which was scheduled to sunset. The bill prevents the council from automatically dissolving by renewing its operational period. The council, composed of 15 voting members (including people with dementia, caregivers, healthcare providers, and researchers) and 5 nonvoting government representatives, examines dementia care needs, reviews state services, and assesses healthcare capacity. It does not create new policies but ensures the council can continue its work on dementia-related issues. This procedural bill affects only the council's continued operation, not direct service recipients.
HB 4869 creates two guaranteed periods for West Virginia seniors to purchase Medicare Supplement (Medigap) policies without medical underwriting or pre-existing condition exclusions. It provides a 60-day window annually around each individual’s birthday for current policyholders to switch to a policy with the same or fewer benefits, and a 63-day window starting the day after Medicaid eligibility ends for those turning 65 or losing Medicaid. Insurers must offer coverage during these periods but are not required to provide new policies or alter existing benefit structures. The bill also mandates annual reports on Medigap premium trends for legislative review but does not change Medicare Advantage plans or require insurers to offer specific rates.
HB 4089, known as "Jessica Huffman's Law," requires health insurers in West Virginia to cover scalp cooling systems for patients undergoing cancer chemotherapy starting January 1, 2027. The bill mandates that any insurance policy covering chemotherapy must include coverage for these devices - described as tools to prevent hair loss during treatment - as defined by Medicare and Medicaid. This applies to policies issued or renewed after 2026, with coverage subject to standard deductibles and coinsurance like other medical benefits. The law directly affects cancer patients seeking hair preservation and insurers offering chemotherapy coverage.
HB 4009, the Portable Benefit Account Act, creates a new legal framework allowing independent contractors to access portable benefits through individually managed accounts. It directly affects independent contractors and hiring parties (businesses that contract with them), enabling voluntary contributions from hiring parties to fund benefits like health insurance, retirement plans, life insurance, and income replacement. Key provisions require written, opt-in agreements for contributions, prohibit using account contributions to determine worker classification, and mandate that accounts remain tied to the contractor - not the employer - when changing jobs. The bill establishes definitions for terms like "portable benefit account" and "provider," and requires administrative oversight by the Bank Commissioner.
HB 4965 allows state employees and retirees covered by the Public Employees Insurance Agency (PEIA) to switch to an alternative medical treatment for the same diagnosed condition without needing new pre-approval, provided the alternative is medically appropriate and costs no more than the originally authorized treatment. The bill requires healthcare providers to document the medical necessity of the switch and ensures PEIA cannot deny coverage solely for not having separate pre-approval. It does not change existing covered benefits or affect treatments for new conditions, and PEIA may still deny claims for fraud or improper billing. This policy aims to reduce delays in care while maintaining cost control for the insurance program.
HB 5004 requires Medicaid and private health insurance plans in West Virginia to cover medically necessary diagnosis and treatment for Pediatric Acute-Onset Neuroimmune Disorders (PANS and PANDAS), as defined by the National Institutes of Health. This directly affects Medicaid enrollees and patients with these conditions, ensuring coverage for diagnostic testing, medications, immune-related treatments, and behavioral services when ordered by a physician and supported by medical evidence. The bill mandates coverage parity for behavioral symptoms, preventing insurers from restricting care solely due to psychiatric manifestations. It also requires the state health department to educate providers on recognizing PANS/PANDAS symptoms, including acute onset, association with strep infections, and neurological symptoms. The legislation applies to all health benefit plans subject to West Virginia's insurance laws.
This bill exempts the West Virginia Department of Health from certain state purchasing restrictions when implementing the federal Rural Health Transformation Program. The legislation allows the state to use federal funds more flexibly to meet the program's strict requirements for rapid deployment and specific use of money in rural healthcare areas. By overriding existing state purchasing laws, the bill ensures the Department of Health can comply with federal guidelines from the Centers for Medicare and Medicaid Services without administrative delays. This change directly affects the state's ability to manage federal grants aimed at improving healthcare infrastructure and services in rural communities.
This bill requires physicians and osteopathic doctors in West Virginia to complete continuing education credits specifically in nutrition as part of their biennial license renewal process. The law mandates that medical professionals earn a minimum of fifty hours of continuing medical education every two years, with osteopathic physicians required to complete thirty-two hours including nutrition training, and these credits must be approved by relevant medical boards. The bill amends existing state code sections to make nutrition education a mandatory component of the continuing education requirement for license renewal.
HB 4610 allows terminally ill patients in West Virginia to access experimental, individually tailored medical treatments (like gene therapies) when standard FDA-approved options have been exhausted. It defines "eligible patients" as those with life-threatening illnesses who have consulted a physician, considered all approved treatments, and provided written consent detailing treatment risks and alternatives. Key provisions require healthcare providers to document patient eligibility, obtain specific informed consent covering potential outcomes, and prohibit debt collection from estates if a patient dies during treatment. The bill also protects healthcare providers from sanctions for offering these treatments and clarifies that it does not affect health insurers' obligations to cover clinical trial participation.
